Vitiligo: A sign of systemic disease

Indian Journal of Dermatology, Venereology and Leprology

Volumn 72, Issue 1, 2006, Pages 68-71

  Huggins, Richard H ^a   Janusz, Christopher A ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Alezzandrini syndrome; Autoimmune diseases; Tuberous sclerosis; Vitiligo; Vogt Koyanagi Harada syndrome

Indexed keywords

ALEZZANDRINI SYNDROME; CLINICAL FEATURE; COLLAGEN DISEASE; DEPIGMENTATION; DISEASE ASSOCIATION; ERYTHRODERMA; HASHIMOTO DISEASE; HUMAN; LEPROSY; MELANOCYTE; MELANOMA; REVIEW; SCLERODERMA; SEZARY SYNDROME; SKIN DISEASE; SYSTEMIC DISEASE; TUBEROUS SCLEROSIS; VITILIGO; VOGT KOYANAGI SYNDROME; WAARDENBURG SYNDROME;

EID: 32044464715     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.19730     Document Type: Review

References (19)

1. Biswas G, Barbhuiya JN, Biswas MC, Islam MN, Dutta S. Clinical pattern of ocular manifestations in vitiligo. J Indian Med Assoc 2003;101:478-80.
2. Huggins RH, Janniger CK, Schwartz RA. Vitiligo. Acta Dermatovenerol Alp Panonica Adriat 2005;14: 137-45.
3. Janniger CK, Koziorynska EI. Alezzandrini's syndrome. eMedicine Dermatology. Last updated 2.12.2005. http:// author.emedicine.com/derm/topic728. htm Last accessed 20.12.2005.
4. Federman DG, Kravetz JD, Ruser CB, Judson PH, Kirsner RS. Vogt-Koyanagi-Harada syndrome and ulcerative colitis. South Med J 2004;97:169-71.
5. Zettinig G, Tanew A, Fischer G, Mayr W, Dudczak R, Weissel M. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exper Immunol 2003;131:347-54.
6. Iacovelli P, Sinagra JL, Vidolin AP, Marenda S, Capitanio B, Leone G, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology 2005;210:26-30.
7. Ortonne JP, Bahadoran P, Fitzpatrick TB, Mosher DB, Hori Y. Hypomelanoses and Hypermelanoses. In: Fitzpatrick's Dermatology in General Medicine. Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, editors. 6th ed. New York: McGraw Hill; 2003. p. 839-47.
8. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003;16:208-14.
9. Hedstrand H, Ekwall O, Olsson MJ, Landgren E, Kemp EH, Weetman AP, et al. The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. J Biol Chem 2001;276:35,390-5.
10. Schwartz RA, Trotter MG. Generalized vitiligo after erythroderma. Dermatologica 1983;167:42-6.
11. Ramírez-Hernández M, Marras C, Martinez-Escribano JA. Infliximab-induced vitiligo. Dermatology 2005;210:79,80.
12. Schwartz RA. Superficial fungal infections. Lancet 2004;364:1173-82.
13. Schwartz RA. Pigmentary disorders. In: Rakel RE, Bope ET, editors. Conn's Current Therapy 2005. Philadelphia: WB Saunders; 2005. p. 995-9.
14. Dourmishev AL, Dourmishev LA, Schwartz RA, Janniger CK. Waardenburg syndrome. Int J Dermatol 1999;38:656-63.
15. Józwiak S, Schwartz RA, Janniger CK, Bialicka-Cymerman J. The usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol 2000;15:652-9.
16. Józwiak S, Schwartz RA. Dermatologic and stomatologic manifestations of tuberous sclerosis. In: Curatolo P, editor. Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes. London: International Child Neurology Association. Mac Keith Press; 2004. p. 136-69.
17. Schwartz RA, Dziankowska-Bartkowiak B, Zalewska A, Sysa-Jedrzejowska A. Systemic sclerosis. eMedicine Dermatology. Last updated 23.08.2005. http://emedicine.com/derm/ topic677.htm. Last accessed 20.12.2005.
18. Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med 2000;192:1637-44.
19. th ed. Philadelphia: JB Lippincott; 1997. Unit 11-33, p. 1-7.